UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 17, 2003
ADVANCED MEDICAL OPTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 01-31257 33-0986820
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1700 E. St. Andrew Place
Santa Ana, CA 92705
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (714) 247-8200
____________________________________________________________
(Former name or former address, if changed since last report)
Item 5. Other Events and Required FD Disclosure.
On July 17, 2003, Advanced Medical Optics, Inc. announced that its Spanish
subsidiary had entered into an agreement with Alcon CUSI, S.A., a
subsidiary of Alcon, Inc., to purchase an existing Alcon manufacturing
facility in Madrid, Spain. AMO will pay approximately $22 million for the
facility, which will be utilized to manufacture AMO eye care products. The
transaction is expected to close in early November, subject to the
satisfaction of regulatory requirements and customary closing conditions.
The press release dated July 17, 2003 with respect thereto is filed as
Exhibit 99.1 hereto and incorporated herein by reference.
On July 17, 2003, AMO also announced the extension of its "Modified Dutch
Auction" tender offer for up to $115 million aggregate principal amount at
maturity of its outstanding 9-1/4% Senior Subordinated Notes due 2010. The
press release dated July 17, 2003 with respect thereto is filed as Exhibit
99.2 hereto and incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99.1 Press release of Registrant, dated July 17, 2003, with respect
to asset acquisition.
99.2 Press release of Registrant, dated July 17, 2003, with respect
to extension of "Modified Dutch Auction" tender offer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ADVANCED MEDICAL OPTICS, INC.
Date: July 17, 2003 By: /s/ Jane E. Rady
----------------------------------
Jane E. Rady, Corporate Vice
President, Strategy and
Technology
INDEX TO EXHIBITS
Number Exhibit
------ -------
99.1 Press release of Registrant, dated July 17, 2003, with respect
to asset acquisition.
99.2 Press release of Registrant, dated July 17, 2003, with respect
to extension of "Modified Dutch Auction" tender offer.